Clariane Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Clariane şirketinin kazançları yıllık ortalama -50.9% oranında azalırken, Healthcare sektörünün kazançları yıllık 31.3% oranında artan oldu. Gelirler yıllık ortalama 8.2% oranında artan oldu.

Anahtar bilgiler

-50.9%

Kazanç büyüme oranı

-98.3%

EPS büyüme oranı

Healthcare Sektör Büyümesi	12.6%
Gelir büyüme oranı	8.2%
Özkaynak getirisi	-3.0%
Net Marj	-2.5%
Sonraki Kazanç Güncellemesi	24 Feb 2025

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Clariane nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

LSE:0OPS Gelir, gider ve kazançlar (EUR Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	5,170	-129	565
31 Mar 24	5,083	-111	555
31 Dec 23	4,996	-92	545
30 Sep 23	4,865	-32	527
30 Jun 23	4,735	28	509
31 Mar 23	4,587	32	483
31 Dec 22	4,438	36	458
30 Jun 22	4,288	85	439
31 Mar 22	4,212	92	434
31 Dec 21	4,137	100	430
30 Sep 21	4,047	76	404
30 Jun 21	3,941	60	425
31 Mar 21	3,857	50	431
31 Dec 20	3,773	39	437
30 Sep 20	3,728	57	446
30 Jun 20	3,683	74	456
31 Mar 20	3,648	94	452
31 Dec 19	3,613	115	449
30 Sep 19	3,542	117	528
30 Jun 19	3,471	119	607
31 Mar 19	3,404	121	686
31 Dec 18	3,336	123	765
30 Sep 18	3,280	152	755
30 Jun 18	3,224	180	744
31 Mar 18	3,177	172	739
31 Dec 17	3,131	163	735
30 Sep 17	3,091	150	736
30 Jun 17	3,052	137	738
31 Mar 17	3,017	134	733
31 Dec 16	2,981	131	728
30 Sep 16	2,880	87	706
30 Jun 16	2,779	42	684
31 Mar 16	2,676	50	674
31 Dec 15	2,573	59	664
30 Sep 15	2,553	77	664
30 Jun 15	2,533	95	664
31 Mar 15	2,378	78	631
31 Dec 14	2,222	61	597
30 Sep 14	1,938	44	526
30 Jun 14	1,654	27	455
31 Mar 14	1,505	28	423
31 Dec 13	1,356	29	391

Kaliteli Kazançlar: 0OPS şu anda kârlı değil.

Büyüyen Kar Marjı: 0OPS şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 0OPS kârlı değildir ve zararlar son 5 yılda yılda 50.9% oranında artmıştır.

Büyüme Hızlandırma: 0OPS 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: 0OPS kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( 15.6% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: 0OPS hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -2.99% ) sahiptir.

Clariane Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Clariane SE to Report Fiscal Year 2024 Results on Feb 24, 2025

First half 2024 earnings released

Full year 2023 earnings released

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

First half 2023 earnings released

Recent updates

Clariane SE, Annual General Meeting, May 14, 2025

Clariane SE to Report Fiscal Year 2024 Results on Feb 24, 2025

Clariane Group Announces Management Changes

First half 2024 earnings released

Clariane Se Provides Earnings Guidance for the Full Year 2024; Reiterates Earnings Guidance for the Full Year from 2023 to 2026

New major risk - Shareholder dilution

Odalys SA acquired Les Essentielles - SARL from Clariane SE (ENXTPA:CLARI).

New minor risk - Shareholder dilution

Clariane SE has filed a Follow-on Equity Offering in the amount of €237.083186 million.

Clariane SE Appoints Sylvia Metayer as Non-Executive Director

Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France

Full year 2023 earnings released

Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million.

Investor sentiment improves as stock rises 20%

Investor sentiment deteriorates as stock falls 17%

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Investor sentiment deteriorates as stock falls 19%

New minor risk - Share price stability

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Investor sentiment deteriorates as stock falls 17%

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 15%

First half 2023 earnings released

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Upcoming dividend of €0.25 per share at 3.4% yield

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 19%

Full year 2022 earnings released

Korian (ENXTPA:KORI) acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others.

Korian to Report First Half, 2023 Results on Jul 27, 2023

Investor sentiment deteriorated over the past week

First half 2022 earnings released

Korian Appoints Philippe Lévêque as Director and Chairman of the Ethics, Quality and CSR Committee

Upcoming dividend of €0.35 per share

Investor sentiment deteriorated over the past week

High number of new directors

Korian Proposes Dividend

Full year 2021 earnings: Revenues in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Icade Santé SAS completed the acquisition of 2 nursing homes in Le Teilleul and Notre-Dame-de-Sanilhac from Korian (ENXTPA:KORI) for €13 million.

Korian Provides Sales Guidance for the Year 2022

First half 2021 earnings released: EPS €0.31 (vs €0.13 in 1H 2020)

Korian (ENXTPA : KORI) acquired a 90% stake in Santa Croce s.r.l.

Korian in Exclusive Talks to Acquire Osny Psychotherapy Centre in Val d’Oise

Icade Santé SAS acquired One Post-Acute Care Facility and Two Nursing Homes from Korian (ENXTPA:KORI).

Korian (ENXTPA:KORI) completed the acquisition of ITA Mental Health from Magnum Capital Industrial Partners.

Korian Approves Dividend, Payable on July 1, 2021

Upcoming dividend of €0.30 per share

Korian Provides Revenue Guidance for the Full Year 2021 and Full Year 2022

Korian (ENXTPA:KORI) signed an agreement to acquire ITA Mental Health from Magnum Capital Industrial Partners.

Revenue beats expectations

Full year 2020 earnings released

Korian (ENXTPA:KORI) acquired unknown minority stake in Viva Son Group.

Korian Demonstrates the Relevance of its Asset Smart Strategy through a Partnership with BNP Paribas Cardif and EDF Invest

New 90-day high: €30.99

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

Korian (ENXTPA:KORI) completed the acquisition of Inicea Groupe from Antin Infrastructure Partners S.A.S.

Korian Signs Development Partnership with Aedifica in the Netherlands

Korian has completed a Follow-on Equity Offering in the amount of €400.250658 million.

Korian to Report First Half, 2021 Results on Jul 29, 2021

New 90-day low: €26.46

Korian to Report Fiscal Year 2020 Results on Feb 24, 2021

New 90-day low: €26.70

Korian (ENXTPA:KORI) reached a non binding deal to acquire Inicea Groupe for €360 million.

Korian Announces Executive Changes

Korian (ENXTPA:KORI) entered into an agreement to acquire Five Facilities near Amsterdam from Ontzorgd Wonen Groep B.V.